Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance Programs
暂无分享,去创建一个
[1] Clinical,et al. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline , 2005 .
[2] Ronald N. Jones,et al. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). , 2004, Diagnostic microbiology and infectious disease.
[3] L. Nicolle,et al. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] F. Dunstan,et al. Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance. , 2004, The Journal of antimicrobial chemotherapy.
[5] D. Talan,et al. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections. , 2004, International journal of antimicrobial agents.
[6] F. Baquero,et al. Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001). , 2002, The Journal of antimicrobial chemotherapy.
[7] F. LuisBavestrello,et al. Impacto de medidas regulatorias en la tendencia de consumo comunitario de antibióticos en Chile , 2002 .
[8] J. Richards. Monitoring antibiotic resistance in urinary isolates from the community--a spotter practice model. , 2002, Communicable disease and public health.
[9] L. Bavestrello,et al. [Impact of regulatory measures in the trends of community consumption of antibiotics in Chile]. , 2002, Revista medica de Chile.
[10] R. Finch,et al. Bacterial resistance--the clinical challenge. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[11] S. Levy,et al. Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. , 2001, The Journal of infectious diseases.
[12] S. Saint,et al. Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome. , 2001, Diagnostic microbiology and infectious disease.
[13] L. Miller,et al. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] T. Hooton,et al. Increasing Antimicrobial Resistance and the Management of Uncomplicated Community-Acquired Urinary Tract Infections , 2001, Annals of Internal Medicine.
[15] Clyde Thornsberry,et al. Multidrug-Resistant Urinary Tract Isolates ofEscherichia coli: Prevalence and Patient Demographics in the United States in 2000 , 2001, Antimicrobial Agents and Chemotherapy.
[16] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[17] S. Levy,et al. Antibiotic and antiseptic resistance: impact on public health , 2000, The Pediatric infectious disease journal.
[18] N. Nagelkerke,et al. Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands. , 2000, The Journal of antimicrobial chemotherapy.
[19] J. Verhoef,et al. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] R C George,et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis , 2000, BMJ : British Medical Journal.
[21] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[22] M. Rodríguez-Carballeira,et al. Emergence and Dissemination of Quinolone-ResistantEscherichia coli in the Community , 1999, Antimicrobial Agents and Chemotherapy.
[23] P. Turner,et al. The MYSTIC (meropenem yearly susceptibility test information collection) programme. , 1999, International journal of antimicrobial agents.
[24] M. Pfaller,et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] A. Schaeffer,et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] D. Livermore,et al. Surveillance of antimicrobial resistance , 1998, BMJ.
[27] T. O'Brien,et al. Surveillance of antimicrobial resistance: the WHONET program. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[29] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.